In vivo effects of interferon-alpha and interferon-gamma on lipolysis and ketogenesis.
The host response to infection and cancer produces disturbances in fatty acid (FA) oxidation and ketogenesis. Interferons (IFNs) stimulate lipolysis in cultured adipocytes. Since FA mobilization is a major stimulus for ketogenesis, we studied the effect of IFN alpha and IFN gamma on lipolysis and ketogenesis in intact mice. Both IFNs acutely stimulated lipolysis; however, their effects on ketogenesis differed. INF gamma increased serum and hepatic ketone body levels in parallel to its effect on serum FFA, whereas IFN alpha exerted a biphasic effect on ketogenesis. At low doses, IFN alpha increased serum and hepatic ketone body levels, whereas at higher doses, this ketogenic effect was abolished. To determine the mechanism of the biphasic response, we studied the effect of IFN alpha on hepatic malonyl-coenzyme-A (malonyl-CoA), the first committed intermediate in FA synthesis and an inhibitor of FA oxidation and ketogenesis. At low doses, IFN alpha had no effect on malonyl-CoA; however, higher doses of IFN alpha significantly increased malonyl-CoA levels, which could counterbalance its mobilization of FFA. In contrast, INF gamma had little effect on malonyl-CoA, and hence, the FA oxidation was not opposed. By using phenylisopropyladenosine to block IFN-induced lipolysis, we found that in the absence of increased FA flux, INF gamma did not exert a ketogenic effect. However, when IFN alpha-induced lipolysis was blocked, the higher doses of IFN alpha that raise malonyl-CoA levels were antiketogenic. These data suggest that both IFNs exert a ketogenic effect by stimulating lipolysis, but at higher doses the ketogenic effect of IFN alpha is counteracted by its effect on hepatic FA synthesis.
Memon
R A
RA
Department of Medicine, University of California, San Francisco.
Feingold
K R
KR
Moser
A H
AH
Doerrler
W
W
Grunfeld
C
C
D020155:3-Hydroxybutyric Acid; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006885:Hydroxybutyrates / Q000097:blood; D016898:Interferon-alpha / Q000494:pharmacology*; D007371:Interferon-gamma / Q000494:pharmacology*; D007657:Ketone Bodies / Q000096:biosynthesis* / Q000097:blood / Q000378:metabolism; D008066:Lipolysis / Q000187:drug effects*; D008099:Liver / Q000378:metabolism; D008297:Male; D008316:Malonyl Coenzyme A / Q000097:blood; D051379:Mice; D008810:Mice, Inbred C57BL; D010660:Phenylisopropyladenosine / Q000494:pharmacology
D005230:Fatty Acids, Nonesterified; D006885:Hydroxybutyrates; D016898:Interferon-alpha; D007657:Ketone Bodies; D010660:Phenylisopropyladenosine; D008316:Malonyl Coenzyme A; D007371:Interferon-gamma; D020155:3-Hydroxybutyric Acid